Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tebentafusp, A TCR/Anti-CD3 Bispecific Fusion Protein Targeting gp100, Potently Activated Antitumor Immune Responses in Patients with Metastatic Melanoma
Mark R. Middleton, Cheryl McAlpine, Victoria K. Woodcock, et al.
Clinical Cancer Research (2020) Vol. 26, Iss. 22, pp. 5869-5878
Open Access | Times Cited: 199

Showing 1-25 of 199 citing articles:

Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma
Paul Nathan, Jessica C. Hassel, Piotr Rutkowski, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 13, pp. 1196-1206
Open Access | Times Cited: 617
Recent Advances in the Treatment of Melanoma
Brendan D. Curti, Mark B. Faries
New England Journal of Medicine (2021) Vol. 384, Iss. 23, pp. 2229-2240
Closed Access | Times Cited: 295
Managing Metastatic Melanoma in 2022: A Clinical Review
Benjamin Switzer, Igor Puzanov, Joseph J. Skitzki, et al.
JCO Oncology Practice (2022) Vol. 18, Iss. 5, pp. 335-351
Open Access | Times Cited: 146
The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma
Lars Ny, Henrik Jespersen, Joakim Karlsson, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 134
Advances in the clinical management of uveal melanoma
Richard D. Carvajal, Joseph J. Sacco, Martine J. Jager, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 2, pp. 99-115
Closed Access | Times Cited: 132
T-cell-engaging bispecific antibodies in cancer
Niels W.C.J. van de Donk, Sonja Zweegman
The Lancet (2023) Vol. 402, Iss. 10396, pp. 142-158
Closed Access | Times Cited: 118
Overcoming Challenges for CD3-Bispecific Antibody Therapy in Solid Tumors
Jim Middelburg, Kristel Kemper, Patrick Engelberts, et al.
Cancers (2021) Vol. 13, Iss. 2, pp. 287-287
Open Access | Times Cited: 105
Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trial
Richard D. Carvajal, Marcus O. Butler, Alexander N. Shoushtari, et al.
Nature Medicine (2022) Vol. 28, Iss. 11, pp. 2364-2373
Open Access | Times Cited: 93
Metastatic uveal melanoma: The final frontier
Elina Rantala, Micaela Hernberg, Sophie Piperno‐Neumann, et al.
Progress in Retinal and Eye Research (2022) Vol. 90, pp. 101041-101041
Closed Access | Times Cited: 90
Tebentafusp: First Approval
Sohita Dhillon
Drugs (2022) Vol. 82, Iss. 6, pp. 703-710
Open Access | Times Cited: 70
T cell receptor therapeutics: immunological targeting of the intracellular cancer proteome
Christopher A. Klebanoff, Smita S. Chandran, Brian M. Baker, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 12, pp. 996-1017
Open Access | Times Cited: 64
Eyedrop-based macromolecular ophthalmic drug delivery for ocular fundus disease treatment
Jingjing Shen, Huiqin Gao, Linfu Chen, et al.
Science Advances (2023) Vol. 9, Iss. 4
Open Access | Times Cited: 41
CAR-T cell therapy targeting surface expression of TYRP1 to treat cutaneous and rare melanoma subtypes
Sameeha Jilani, Justin D. Saco, Edurne Mugarza, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 17
Bispecific antibodies
Ulrich Brinkmann, Roland E. Kontermann
Science (2021) Vol. 372, Iss. 6545, pp. 916-917
Closed Access | Times Cited: 97
Bispecific Immunomodulatory Antibodies for Cancer Immunotherapy
Belén Blanco, Carmen Domínguez-Alonso, Luis Álvarez‐Vallina
Clinical Cancer Research (2021) Vol. 27, Iss. 20, pp. 5457-5464
Open Access | Times Cited: 85
CAR-T cells and BiTEs in solid tumors: challenges and perspectives
Julien Edeline, Roch Houot, Aurélien Marabelle, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 74
The state of the art of bispecific antibodies for treating human malignancies
Shuhang Wang, Kun Chen, Qi Lei, et al.
EMBO Molecular Medicine (2021) Vol. 13, Iss. 9
Open Access | Times Cited: 63
A review on targeting tumor microenvironment: The main paradigm shift in the mAb-based immunotherapy of solid tumors
Ayuob Aghanejad, Samad Farashi Bonab, Maryam Sepehri, et al.
International Journal of Biological Macromolecules (2022) Vol. 207, pp. 592-610
Closed Access | Times Cited: 59
Phase I Study of Safety, Tolerability, and Efficacy of Tebentafusp Using a Step-Up Dosing Regimen and Expansion in Patients With Metastatic Uveal Melanoma
Richard D. Carvajal, Paul Nathan, Joseph J. Sacco, et al.
Journal of Clinical Oncology (2022) Vol. 40, Iss. 17, pp. 1939-1948
Open Access | Times Cited: 57
Therapeutic high affinity T cell receptor targeting a KRASG12D cancer neoantigen
Andrew J. Poole, V. Karuppiah, Annabelle Hartt, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 56
Recent Advances and Challenges in Uveal Melanoma Immunotherapy
Yihang Fu, Wei Xiao, Yuxiang Mao
Cancers (2022) Vol. 14, Iss. 13, pp. 3094-3094
Open Access | Times Cited: 43
Strategies for clinical dose optimization of T cell-engaging therapies in oncology
Kathryn Ball, Simon J. Dovedi, Pavan Vajjah, et al.
mAbs (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 38
Tebentafusp: a first-in-class treatment for metastatic uveal melanoma
Sarah Howlett, Thomas J. Carter, Heather M. Shaw, et al.
Therapeutic Advances in Medical Oncology (2023) Vol. 15
Open Access | Times Cited: 32
The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells
Jianping Li, Zhiwen Xiao, Donghui Wang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 27
Current management of uveal melanoma: A review
Hai-Xia Bai, Jacobus Bosch, Ludwig M. Heindl
Clinical and Experimental Ophthalmology (2023) Vol. 51, Iss. 5, pp. 484-494
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top